Oncobesity News Posts

#JPM26: Sandoz CEO on Ozempic generic launch plans for 2026
SAN FRANCISCO — Throughout his 53 meetings at this year’s JPMorgan Healthcare Conference, Richard Saynor mulled a charitable idea about the topic on everyone’s minds.

Resmed highlights AI-driven CPAP tech, competitive bidding win and GLP-1 insights at J.P. Morgan Hea – HME News
Resmed highlights AI-driven CPAP tech, competitive bidding win and GLP-1 insights at J.P. Morgan Hea HME News

Signal Boost 2026
Signal Boost 2026 Second week of January. Year of the Horse. Back in the saddle. As I point my GPS toward a familiar constellation of

What Contributes to Lifecore Biomedical’s (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns

Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli
Fermentation, Vol. 12, Pages 53: High Cell Density Fermentation Strategy for High-Level Soluble Expression of Glucagon-like Peptide-1 Analogue in Escherichia coli Fermentation doi: 10.3390/fermentation12010053 Authors:

The Biological Cost of Ozempic and Other GLP-1s
Get the Highest Quality Electrolyte https://euvexia.com . Losing belly fat is hard so you may wonder if a GLP-1 will work. The question isn’t whether

David Protein CEO Peter Rahal on the rise of protein bars, impact of GLP-1s and protein intake
Peter Rahal, David Protein CEO, joins ‘Squawk Box’ to discuss the rise and advancements of protein bars, the supplementation of creatine, impact of GLP-1 weight

Glucagon-like peptide-1 medicines and cancer
Nature Cancer, Published online: 16 January 2026; doi:10.1038/s43018-025-01110-1 Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer

Weight-loss drugs may trigger the next restaurant crisis
Chad Finkelstein is a partner at the law firm of Dale & Lessmann LLP and chair of the firm’s franchising, licensing and distribution group. His

GLP-1 pills, immunology, and China, oh my: JPM 2026
At biopharma’s biggest conference, leaders plot strategy

Oprah Winfrey Recalls When Joan Rivers Fat-Shamed Her
Oprah Winfrey is no stranger to the limelight or public scrutiny. But her negative experience with the late Joan Rivers is still something that sticks

Teens ‘Struggle’ With A Common New Year’s Obsession – And It’s Pretty Dangerous
Like clockwork, the turn of the new calendar year always brings a slew of chatter about weight loss, diets and exercise. Whether it’s in the form

Why GLP-1 Drugs Trigger Hair Loss
Hair loss often shows up when something deeper in your metabolism starts to break down, and glucagon-like peptide-1 (GLP-1) drugs push that process forward in

Eli Lilly -5%, Novo Nordisk -4% after compounding pharmacy files federal antitrust lawsuit over GLP-1 competition
Source: https://finance.yahoo.com/news/strive-compounding-pharmacy-files-landmark-200600637.html Strive Compounding Pharmacy, one of the nation’s most celebrated providers of compounded medications, has filed a federal antitrust lawsuit against pharmaceutical giants Eli

Why GLP-1 users are ditching injections and turning to other weight-loss methods
Post Content

Trump pitches healthcare policy outline aimed at lowering costs: 3 takeaways
President Donald Trump released a sparsely detailed healthcare policy framework Jan. 15 that calls on Congress to codify voluntary drug pricing agreements with major pharmaceutical

Real Housewife Heather Gay, 51, reveals if she will stop GLP-1 after dramatic weight loss
Now the 51-year-old reality star has shared if she plans to go off the weight loss drug. The answer is a big no, even though

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s – Sherwood News
Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s Sherwood News Strive Compounding Pharmacy Files Landmark Antitrust Lawsuit Against Eli Lilly and Novo Nordisk Yahoo

Ashton Kutcher Makes Rare Comment About Ex-Wife Demi Moore
Ashton Kutcher has no love lost for his ex-wife, Demi Moore. “Demi’s performance in The Substance, obviously, got extraordinary accolades. I’m so proud of her,”

How to Spot a Fake GLP-1 Weight-Loss Drug Before You Buy
“I thought I was getting a trusted weight-loss medication, but instead, I ended up sick and scammed. I never imagined something like this could happen to me.”

GLP-1 Medications: Conversations and Considerations
The discussion surrounding GLP-1 medications needs to change to one that emphasizes science-based research and compassion.

“There Is No Way This Is Healthy”: Kelly Osbourne Fans Urge Her To Seek Help After Recent Video
Kelly Osbourne has once again triggered a fresh wave of concerns about her health after a recent video featuring her and her 3-year-old son went

GLP-1s tied to improved survival in colorectal cancer
Use of GLP-1 medications was associated with lower long-term mortality among patients with colorectal cancer and obesity, according to research presented at an oncology conference.

Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs
The GLP-1 giants are the first to try out this new model, but more companies may follow.

Heather Gay talks weight struggles, finding confidence with a GLP-1
Heather Gay reveals how weight shaped her identity and why her journey with a GLP-1 has been life-changing.

Many People Who Come Off GLP-1 Drugs Regain Weight Within 2 Years, Review Suggests
Many people who stop using weight loss drugs will return to their previous weight within two years, a new review of existing research has found.

Animals, Vol. 16, Pages 259: Bifidobacterium animalis Subspecies lactis CECT 8145 Affects Markers of Metabolic Health in Dogs During Weight Gain and Weight Loss
Animals, Vol. 16, Pages 259: Bifidobacterium animalis Subspecies lactis CECT 8145 Affects Markers of Metabolic Health in Dogs During Weight Gain and Weight Loss Animals

5 ingredient trends driving the next wave of GLP-1 innovation
Discover the top five ingredient trends driving GLP-1 innovation in the food and beverage industry. From proteins and fibers to metabolic health, learn how these

Exclusive: Beyond pivots again, this time with a sports recovery drink
Fifty minutes into a training session at a gym in lower Manhattan, I’m doing burpees and clean-and-jerks while Beyond Meat CEO Ethan Brown—all 6 feet,


Health Care Roundup: Market Talk
1937 GMT – GLP-1 medications haven’t seemed to make a dent on restaurant demand so far, but that could change as the drugs become cheaper

Why nutrient-dense crops matter in the age of GLP-1
Over the past half-century, nutrients in crops have declined significantly. Levels of key nutrients and ingredients such as zinc, magnesium, iron and protein have declined.

Playlist, EGYM announce $7.5 billion merger
Fritz Lanman, Playlist CEO, and Philipp Roesch-Schlanderer, EGYM CEO, join ‘Squawk Box’ to discuss the merger of the two companies, impact on the fitness and

Viking Therapeutics (VKTX) Soars 11.9% on Strong Weight Loss Market Outlook
We recently published 10 Big Names Delivering Outsized Gains. Viking Therapeutics Inc. (NASDAQ:VKTX) was one of the top performers on Wednesday. Viking Therapeutics grew its

FDA Moves To Remove Suicide Warnings From GLP-1 Weight Loss Drugs
By I. Edwards HealthDay ReporterTHURSDAY, Jan. 15, 2026 (HealthDay News) — Federal health regulators say popular weight loss drugs like Wegovy and…

Hershey unveils new dream candy combos ahead of Valentine’s Day
Many of us remember Valentine’s Day from childhood, when we begged our parents to buy oversized bags of candy so we could carefully write “to”

Lifeway To Launch Kefir Butter, Eyes Record Sales on GLP-1 Tailwinds
On the back of rising consumer demand for probiotic foods and expanded distribution partnerships with mainstream retailers, Lifeway Foods is projecting record growth for fiscal

Rich People Are Getting Dead People’s Fat Injected Into Their Lips and Butts
It’s such a spot-on allegory for the problems of the modern world that it feels almost too on the nose. A little too perfect. A

What Is the Hims Weight Loss Treatment Plan All About?
Weight loss advice on the internet has become a two-option menu: obsess over food or inject yourself. Scroll long enough and you’ll find both from

Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access
Strive Compounding Pharmacy filed a federal antitrust lawsuit Jan. 14 against Eli Lilly and Novo Nordisk, alleging the two drugmakers used their market power to